Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...

Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ones, offering hope for patients with advanced stages of the disease.

Serum DR-70 levels are higher in bladder cancer patients, especially in muscle-invasive cases, indicating potential for diagnosis and staging. Current diagnostic methods for bladder cancer are ...

BBC apologizes to Trump over editing blunder, rejects defamation claim Scientists Studied 'SuperAgers' For 25 Years And Found ...

Growth hormone receptor (GHR) signaling in bladder cancer is associated with advanced tumor stages and poor survival outcomes. High GHR expression in tumors up-regulates genes involved in drug ...

The IMvigor010 trial showed that Signatera-guided treatment with Tecentriq improved disease-free survival and overall ...

According to researcher Anne Robertson, the bladder is not considered a particularly glamorous organ, despite hosting many of ...

Following the 2025 European Society for Medical Oncology (ESMO) Annual Congress held in Berlin, Germany, we sat down with leading experts in oncology to discuss the latest advances in bladder cancer ...

Patients with initially low- or intermediate-risk primary tumors will often have a high-risk recurrence before progressing to more advanced disease, whereas primary high-risk tumors typically show ...

After years as a surgeon, Dr. Lishan Aklog now leads Lucid Diagnostics, a subsidiary of Pavmed, as it advances its unique ...

Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.

Park says patient-specific factors that influence his treatment selection include the presence of liver disease, ...